Metformin 1000 mg

DRUG4 trials

Sponsors

Sanofi, Brigham and Women's Hospital, Galala University, Beni-Suef University

Conditions

Diabete Type 2HealthyInduction of OvulationNon Alcoholic Fatty LiverPeripheral Artery Disease

Phase 1

A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib

CompletedNCT01551615

Start: 2012-03-31End: 2012-06-30Updated: 2016-08-29

Phase 4

Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease

TerminatedNCT01901224

Brigham and Women's HospitalPeripheral Artery Disease

Start: 2013-07-31End: 2015-06-30Updated: 2018-09-24

Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation

CompletedNCT07589075

Beni-Suef UniversityInduction of Ovulation

Start: 2023-10-20End: 2025-10-30Updated: 2026-05-15

Unknown Phase

Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

CompletedNCT07338331

Galala UniversityDiabete Type 2, Non Alcoholic Fatty Liver

Start: 2023-04-04End: 2025-09-19Updated: 2026-08-13

Related Papers

Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidine.

2014-09-0144 citations